Jhaveri KL, Lim E, Jeselsohn R, Ma CX, et al. Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study. J Clin Oncol 2024 Sep 6:JCO2302733. doi: 10.1200/JCO.23.02733.
PMID: 39241211